These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 15181415

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].
    Llinares Tello F, Hernández Prats C, Burgos San José A, Bosacoma Ros N, Alcalá Minagorre P, López Rodríguez F, Reig Sáenz R, Marco Vera P, Ordovás Baines JP.
    Farm Hosp; 2004; 28(2):130-6. PubMed ID: 15101805
    [Abstract] [Full Text] [Related]

  • 23. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
    Degoricija V, Sharma M, Legac A, Gradiser M, Sefer S, Vucicević Z.
    Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Beneficial effects of recombinant human activated protein C in a ewe model of septic shock.
    Wang Z, Su F, Rogiers P, Vincent JL.
    Crit Care Med; 2007 Nov; 35(11):2594-600. PubMed ID: 17901839
    [Abstract] [Full Text] [Related]

  • 26. Antithrombin replacement in patients with sepsis and septic shock.
    Giudici D, Baudo F, Palareti G, Ravizza A, Ridolfi L, D' Angelo A.
    Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Plasma antioxidant status in septic critically ill patients: a decrease over time.
    Doise JM, Aho LS, Quenot JP, Guilland JC, Zeller M, Vergely C, Aube H, Blettery B, Rochette L.
    Fundam Clin Pharmacol; 2008 Apr; 22(2):203-9. PubMed ID: 18353115
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study.
    du Cheyron D, Bouchet B, Bruel C, Daubin C, Ramakers M, Charbonneau P.
    Crit Care; 2006 Apr; 10(2):R45. PubMed ID: 16542495
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability.
    Waeschle RM, Moerer O, Hilgers R, Herrmann P, Neumann P, Quintel M.
    Crit Care; 2008 Apr; 12(5):R129. PubMed ID: 18939991
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock.
    Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettilä V, FINNSEPSIS Study Group.
    Crit Care Med; 2007 May; 35(5):1277-83. PubMed ID: 17414731
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.